From weight loss to lowered cholesterol, our patients are experiencing significant improvements in their health and seeing exciting results
Plateau Phase (Months 49): Weight loss slows, but body-shape improvements continue
Adolescents will follow the same titration schedule, instead of starting at a higher dose
Non-diabetic users also showed improvements in cardiovascular risk factors including blood pressure, cholesterol, and inflammatory markers
Yes, its possible to experience burping as a standalone symptom without other significant digestive issues while on Semaglutide
This matters because GLP-1 medications work by activating specific receptor pathways that influence appetite, blood sugar, and gastrointestinal function